Skip to main
CV

CapsoVision Inc (CV) Stock Forecast & Price Target

CapsoVision Inc (CV) Analyst Ratings

Based on 1 analyst ratings
Buy
Strong Buy 0%
Buy 100%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

CapsoVision Inc. has demonstrated a positive financial trajectory, achieving nearly $12 million in revenue during 2024 from the CapsoCam Plus, which has been utilized in over 135,000 procedures, indicating strong market share gains. This consistent growth is exemplified by an annual revenue increase since the company's entry into the U.S. market, signifying ongoing demand for its innovative endoscopic video imaging technology. The promising future potential is further amplified by the company's development of the CapsoColon 3D, aimed at the large intestines, showcasing its commitment to expanding its product portfolio in the gastrointestinal imaging sector.

Bears say

CapsoVision Inc. faces significant challenges that could hinder its revenue growth and delay profitability, primarily due to resistance from physicians, hospitals, and patients regarding the retrieval of its capsule after ingestion. Additionally, potential disruptions in manufacturing, negative clinical outcomes, or product recalls could further undermine investor confidence and negatively impact revenue streams. The requirement for a CE mark may also restrict the sale of CapsoCam Plus, limiting the company’s growth potential, especially in new markets such as pediatric applications and fully digestible methods.

CapsoVision Inc (CV) has been analyzed by 1 analysts, with a consensus rating of Buy. 0% of analysts recommend a Strong Buy, 100% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of CapsoVision Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CapsoVision Inc (CV) Forecast

Analysts have given CapsoVision Inc (CV) a Buy based on their latest research and market trends.

According to 1 analysts, CapsoVision Inc (CV) has a Buy consensus rating as of Dec 24, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $5, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $5, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CapsoVision Inc (CV)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.